Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving leading biopharmaceutical companies globally:

Last Updated: December 6, 2019

DrugPatentWatch Database Preview

B - Biologic Drug Details

See Plans and Pricing

« Back to Dashboard

Company Disclosures: US Patents for b

These patents were extracted from company disclosures

Subscribe to access the full database, or Start Trial
Applicant	Tradename	Biologic Ingredient	Dosage Form	BLA	Number	Approval Date	Patent No.	Assignee	Estimated Patent Expiration	Status	Orphan	Source
Genentech	AVASTIN	bevacizumab	VIAL; INTRAVENOUS	125085	001	2004-02-26	Start Trial	Athena Neurosciences, Inc. (South San Francisco, CA)	2014-01-25	RX	Orphan	company
Genentech	AVASTIN	bevacizumab	VIAL; INTRAVENOUS	125085	001	2004-02-26	Start Trial	Biogen, Inc. (Cambridge, MA)	2020-08-05	RX	Orphan	company
Genentech	AVASTIN	bevacizumab	VIAL; INTRAVENOUS	125085	002	2004-02-26	Start Trial	Athena Neurosciences, Inc. (South San Francisco, CA)	2014-01-25	RX	Orphan	company
Genentech	AVASTIN	bevacizumab	VIAL; INTRAVENOUS	125085	002	2004-02-26	Start Trial	Biogen, Inc. (Cambridge, MA)	2020-08-05	RX	Orphan	company
Amgen	BLINCYTO	blinatumomab	INJECTABLE;INJECTION	125557	001	2014-12-03	Start Trial	Micromet AG (Munich, DE)	2018-04-21	RX	Orphan	company
>Applicant	>Tradename	>Biologic Ingredient	>Dosage Form	>BLA	>Number	>Approval Date	>Patent No.	>Assignee	>Estimated Patent Expiration	>Status	>Orphan	>Source

Patent Text Search: US Patents for b

These patents were identified by searching patent claims

Subscribe to access the full database, or Start Trial
Applicant	Tradename	Biologic Ingredient	Dosage Form	BLA	Number	Approval Date	Patent No.	Assignee	Estimated Patent Expiration	Status	Orphan	Source
Seattle Genetics	ADCETRIS	brentuximab vedotin	INJECTABLE; INJECTION	125388	001	2011-08-19	Start Trial	University of Georgia Research Foundation, Inc. (Athens, GA)	2039-02-26	RX	Orphan	search
Seattle Genetics	ADCETRIS	brentuximab vedotin	INJECTABLE; INJECTION	125388	001	2011-08-19	Start Trial	SUNSHINE LAKE PHARMA CO., LTD. (Dongguan, Guangdong, CN)	2034-07-17	RX	Orphan	search
Seattle Genetics	ADCETRIS	brentuximab vedotin	INJECTABLE; INJECTION	125388	001	2011-08-19	Start Trial	CureVac AG (Tubingen, DE)	2032-02-15	RX	Orphan	search
Seattle Genetics	ADCETRIS	brentuximab vedotin	INJECTABLE; INJECTION	125388	001	2011-08-19	Start Trial	Celgene Corporation (Summit, NJ)	2035-12-02	RX	Orphan	search
Seattle Genetics	ADCETRIS	brentuximab vedotin	INJECTABLE; INJECTION	125388	001	2011-08-19	Start Trial	SEATTLE GENETICS, INC. (Bothell, WA)	2030-10-22	RX	Orphan	search
>Applicant	>Tradename	>Biologic Ingredient	>Dosage Form	>BLA	>Number	>Approval Date	>Patent No.	>Assignee	>Estimated Patent Expiration	>Status	>Orphan	>Source

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Baxter

Express Scripts

Medtronic

Dow

McKesson

McKinsey

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

By using our website you are consenting to our use of cookies in accordance with our privacy policy.